- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00536432
Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot
Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot: Prospective Analysis of Myocardial Benefit Using Cardiac MRI and Echocardiography
Tetralogy of Fallot is one of the most frequent congenital heart malformations. In many cases re-interventions, surgical or catheter-based, are necessary after the repair of tetralogy of Fallot in infancy. At present, informations in the literature about the myocardial benefit and the timing of re-interventions are missing in this age group. On the other hand, Fallot patients are dependent on solid criteria for re-interventions, because further interventions like replacement of the pulmonary valve or balloon dilatations of peripheral pulmonary stenoses are common.
The objective of this study is to assess the benefit of such interventions for the right ventricular function. By performing extensive standardised examinations (including MRI, echocardiography, tissue Doppler,,3D-echocardiography, holter monitoring and quality of life assessments) before and 6 to 9 months after the re-intervention data of the right ventricular function are collected. Based on these quantitative data predictive parameters concerning the right ventricular recovery and information about the time of re-intervention should be determined.
Study Overview
Status
Conditions
Detailed Description
In the repair of tetralogy of Fallot, pulmonary insufficiency used to be tacitly accepted as a result of extensive transannular patching (TAP) and considered unobjectionable. In fact, this is well tolerated during the first postoperative years, but today there is increasing evidence that the resulting chronic volume stress to the right ventricle is harmful on the long run, in particular if there are stenoses of the pulmonary artery in addition. Such stenoses, partly due to distortions after shunt surgery, together with pulmonary insufficiency, lead to a combined volume and pressure load of the right ventricle. The chronic volume stress results in a decrease in biventricular function and exercise tolerance, associated with increasing electrical instability with frequent, mostly ventricular, dysrhythmias. This constellation brings about a significantly increased risk of cardiac death.
Pulmonary valve replacement can improve haemodynamics, exercise tolerance and dysrhythmia. However, it is still unclear, which criteria best indicate the need for re-intervention, such as balloon dilatations of peripheral pulmonary stenoses, and what may be the best point in time in infancy.
The objective of this study is to assess the effectiveness of such interventions to the right ventricular function in small children. The data obtained are supposed to determine predictive parameters of the right ventricular recovery and to help to establish criteria for the necessity and time of re-intervention.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, D-13353
- Deutsches Herzzentrum Berlin
-
Berlin, Germany, D-13353
- Universitätsklinikum Charite, Campus Virchow-Klinikum, Otto-Heubner-Centrum für Kinder- und Jugendmedizin
-
-
Baden-Wuerttemberg
-
Freiburg, Baden-Wuerttemberg, Germany, D-79106
- Universitätsklinikum Freiburg, Klinik III Päd. Kardiologie
-
Tuebingen, Baden-Wuerttemberg, Germany, D-72076
- Universitätsklinikum Tuebingen, Klinik für Kinderheilkunde und Jugendmedizin
-
-
Bavaria
-
Munich, Bavaria, Germany, D-80636
- Deutsches Herzzentrum Muenchen
-
-
Lower Saxony
-
Hannover, Lower Saxony, Germany, D-30625
- Medizinische Hochschule Hannover, Pädiatrische Kardiologie und Intensivmedizin
-
-
North Rhine-Westphalia
-
Bad Oeynhausen, North Rhine-Westphalia, Germany, D-32545
- Herz- und Diabeteszentrum Nordrhein-Westfalen
-
Duisburg, North Rhine-Westphalia, Germany, D-47137
- Herzzentrum Duisburg, Kinderkardiologie
-
Essen, North Rhine-Westphalia, Germany, D-45122
- Universitätsklinikum Essen, Klinik für Kinderkardiologie
-
Muenster, North Rhine-Westphalia, Germany, D-48149
- Universitätsklinikum Muenster, Klinik für Kinderkardiologie
-
Sankt Augustin, North Rhine-Westphalia, Germany, D-53757
- Deutsches Kinderherzzentrum St. Augustin
-
-
Saarland
-
Homburg/Saar, Saarland, Germany, D-66421
- Universitätsklinikum des Saarlandes, Klinik für Pädiatrische Kardiologie
-
-
Saxony
-
Leipzig, Saxony, Germany, D-04289
- Herzzentrum Leipzig, Klinik für Kinderkardiologie
-
-
Schleswig-Holstein
-
Kiel, Schleswig-Holstein, Germany, D-24105
- Universitätsklinikum Schleswig-Holstein Campus Kiel, Klinik für Kinderkardiologie
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Written informed consent of the patient's legal representatives
- Patients with tetralogy of Fallot (including pulmonary atresia with vsd) after corrective operation
- Patients < 8 years with corrective surgery and necessary re-intervention (e.g.cardiac catheter intervention or re-operation )
Exclusion Criteria:
- DORV (if there is another VSD than subaortic)
- Associated severe heart defects (e. g. AV canal)
- Other clinically relevant diseases, such as malignant tumor (in the investigating physician's assessment)
- MRI contraindication, e.g. cardiac pacemaker, implanted neurostimulators and other magnetizable foreign bodies
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Samir Sarikouch, MD, Medizinische Hochschule Hannover, Lower Saxony
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MP 4.2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tetralogy of Fallot
-
Shanghai Jiao Tong University School of MedicineCompletedCongenital Heart Defects | Tetralogy Of FallotChina
-
Assiut UniversityNot yet recruiting
-
University of California, San FranciscoCompletedPulmonary Regurgitation After Repair of Tetralogy of FallotUnited States
-
Ain Shams UniversityRecruiting
-
Assiut UniversityUnknown
-
Indonesia UniversityCompletedMyocardial Injury | Cardiac SurgeryIndonesia
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingCongenital Heart Disease | Congenital Heart Defect | Fallot TetralogySpain
-
Assistance Publique Hopitaux De MarseilleCompletedTetralogy of Fallot With Pulmonary StenosisFrance
-
Nationwide Children's HospitalCompletedTetralogy of Fallot (TOF) | Ventricular Septal Defects (VSD) | Atrioventricular Septal Defects (AVSD)United States
-
Paris Cardiovascular Research Center (Inserm U970)European Georges Pompidou Hospital; Centre Chirurgical Marie Lannelongue; Hôpital... and other collaboratorsRecruitingCongenital Heart Disease | Ventricular Arrythmia | Pulmonary Valve Regurgitation | Fallot TetralogyFrance